{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:22:00Z","timestamp":1794075720236,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Corporation de recherche et d'action sur les maladies h\u00e9r\u00e9ditaires"},{"name":"Groupe de recherche interdisciplinaire sur les maladies neuromusculaires"},{"name":"Fonds de recherche du Qu\u00e9bec \u2013 Sant\u00e9","award":["31011"],"award-info":[{"award-number":["31011"]}]},{"name":"CIHR Emerging team","award":["TR2\u2013119189"],"award-info":[{"award-number":["TR2\u2013119189"]}]},{"name":"CIHR Emerging team","award":["TR2\u2013119189"],"award-info":[{"award-number":["TR2\u2013119189"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["441409627"],"award-info":[{"award-number":["441409627"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["441409627"],"award-info":[{"award-number":["441409627"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Joint Programme on Rare Diseases","award":["825575"],"award-info":[{"award-number":["825575"]}]},{"name":"European Joint Programme on Rare Diseases","award":["825575"],"award-info":[{"award-number":["825575"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-023-01565-x","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T04:29:32Z","timestamp":1683779372000},"page":"512-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Development of a New Patient-Reported Outcome Measure in Recessive Ataxias: The Person-Reported Ataxia Impact Scale"],"prefix":"10.1007","volume":"23","author":[{"given":"Marjolaine","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Asselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamal","family":"Berbiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1172-1-47","volume":"1","author":"F Palau","year":"2006","unstructured":"Palau F, Espin\u00f3s C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47\u201347.","journal-title":"Orphanet J Rare Dis"},{"key":"1565_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-444-64189-2.00005-6","volume":"155","author":"M Synofzik","year":"2018","unstructured":"Synofzik M, N\u00e9meth AH. Recessive ataxias. Handb Clin Neurol. 2018;155:73\u201389.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"1565_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/WCO.0b013e32832b9897","volume":"22","author":"M Manto","year":"2009","unstructured":"Manto M, Marmolino D. Cerebellar ataxias. Curr Opin Neurol. 2009;22(4):419\u201329.","journal-title":"Curr Opin Neurol"},{"key":"1565_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-8-41","volume":"8","author":"M Synofzik","year":"2013","unstructured":"Synofzik M, et al. Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum. Orphanet J Rare Dis. 2013;8:41.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1565_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ncl.2020.01.008","volume":"38","author":"KT Kwei","year":"2020","unstructured":"Kwei KT, Kuo SH. An overview of the current state and the future of ataxia treatments. Neurol Clin. 2020;38(2):449\u201367.","journal-title":"Neurol Clin"},{"key":"1565_CR6","volume-title":"Roadmap to patient-focused outcome measurement in clinical trials","author":"Food and Drug Administration","year":"2013","unstructured":"Food and Drug Administration. Roadmap to patient-focused outcome measurement in clinical trials. Silver Spring: Department of Health and Human Services, Food and Drug Administration; 2013."},{"key":"1565_CR7","first-page":"16","volume-title":"Principles for selecting, developing, modifying, and adapting patient-reported outcome instruments for use in medical device evaluation. Guidance for Industry and Food and Drug Administration Staff, and Other Stakeholders","author":"Food and Drug Administration","year":"2022","unstructured":"Food and Drug Administration. Principles for selecting, developing, modifying, and adapting patient-reported outcome instruments for use in medical device evaluation. Guidance for Industry and Food and Drug Administration Staff, and Other Stakeholders. Rockville: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2022. p. 16."},{"key":"1565_CR8","first-page":"39","volume-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims","author":"Food and Drug Administration","year":"2009","unstructured":"Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Rockville: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2009. p. 39."},{"issue":"5","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1046\/j.1524-4733.2003.65309.x","volume":"6","author":"C Acquadro","year":"2003","unstructured":"Acquadro C, et al. Incorporating the patient\u2019s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522\u201331.","journal-title":"Value Health"},{"key":"1565_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2017.04.013","volume":"89","author":"NE Mayo","year":"2017","unstructured":"Mayo NE, et al. Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 2: terminology proposed to measure what matters in health. J Clin Epidemiol. 2017;89:119\u201324.","journal-title":"J Clin Epidemiol"},{"key":"1565_CR11","volume-title":"Foundations of clinical research: applications to practice","author":"LG Portney","year":"2009","unstructured":"Portney LG, Watkins MP. Foundations of clinical research: applications to practice. New Jersey: Pearson\/Prentice Hall; 2009."},{"issue":"9","key":"1565_CR12","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00415-018-8954-0","volume":"265","author":"H Jacobi","year":"2018","unstructured":"Jacobi H, et al. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias. J Neurol. 2018;265(9):2040\u201351.","journal-title":"J Neurol"},{"key":"1565_CR13","doi-asserted-by":"crossref","unstructured":"Schmahmann JD, et al. Development and validation of a patient\u2010reported outcome measure of ataxia. Mov Disord. 2021;36(10):2367\u201377.","DOI":"10.1002\/mds.28670"},{"issue":"7","key":"1565_CR14","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/mds.22420","volume":"24","author":"SJ Cano","year":"2009","unstructured":"Cano SJ, et al. Friedreich\u2019s ataxia impact scale: a new measure striving to provide the flexibility required by today\u2019s studies. Mov Disord. 2009;24(7):984\u201392.","journal-title":"Mov Disord"},{"issue":"3","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1521-6942(03)00025-1","volume":"17","author":"G Stucki","year":"2003","unstructured":"Stucki G, Sigl T. Assessment of the impact of disease on the individual. Best Pract Res Clin Rheumatol. 2003;17(3):451\u201373.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1565_CR16","first-page":"58","volume-title":"Designing and conducting mixed methods research","author":"JW Creswell","year":"2011","unstructured":"Creswell JW, Plano VL. Clark, Choosing a mixed methods design. In: Designing and conducting mixed methods research. 2nd ed. SAGE Publications: Los Angeles; 2011. p. 58\u201388.","edition":"2"},{"issue":"8","key":"1565_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, et al. Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967\u201377.","journal-title":"Value Health"},{"issue":"1","key":"1565_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hex.12442","volume":"20","author":"B Wiering","year":"2017","unstructured":"Wiering B, de Boer D, Delnoij D. Patient involvement in the development of patient-reported outcome measures: a scoping review. Health Expect. 2017;20(1):11\u201323.","journal-title":"Health Expect"},{"issue":"5","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.2010.135129","volume":"70","author":"MP de Wit","year":"2011","unstructured":"de Wit MP, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis. 2011;70(5):722\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1565_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/hex.12048","volume":"18","author":"MP de Wit","year":"2015","unstructured":"de Wit MP, et al. Do not forget the professional\u2013the value of the FIRST model for guiding the structural involvement of patients in rheumatology research. Health Expect. 2015;18(4):489\u2013503.","journal-title":"Health Expect"},{"issue":"4","key":"1565_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/art.22091","volume":"55","author":"S Hewlett","year":"2006","unstructured":"Hewlett S, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum. 2006;55(4):676\u201380.","journal-title":"Arthritis Rheum"},{"key":"1565_CR22","unstructured":"National Institutes of Health. Patient-Reported Outcomes Measurement Information System (PROMIS) Mid-Course Review Report. 2007; 35. Available from: https:\/\/dpcpsi.nih.gov\/sites\/default\/files\/opep\/document\/Final_Report_(07-1014-R_NIAMS)_2007.pdf.\u00a0Accessed 19 Apr 2018."},{"issue":"1","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13023-022-02497-1","volume":"17","author":"M Tremblay","year":"2022","unstructured":"Tremblay M, et al. Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome. Orphanet J Rare Dis. 2022;17(1):369.","journal-title":"Orphanet J Rare Dis"},{"key":"1565_CR24","volume-title":"L'analyse qualitative en sciences humaines et sociales","author":"P Paill\u00e9","year":"2008","unstructured":"Paill\u00e9 P, Mucchielli A. L\u2019analyse qualitative en sciences humaines et sociales. 2nd ed. Paris: Armand Colin; 2008.","edition":"2"},{"issue":"3","key":"1565_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/erp.10.30","volume":"10","author":"C Kerr","year":"2010","unstructured":"Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):269\u201381.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"1565_CR26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1524-4733.2009.00603.x","volume":"12","author":"M Rothman","year":"2009","unstructured":"Rothman M, et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO Task Force Report. Value in Health. 2009;12(8):1075\u201383.","journal-title":"Value in Health"},{"issue":"1","key":"1565_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.apnr.2005.06.001","volume":"19","author":"EJ Halcomb","year":"2006","unstructured":"Halcomb EJ, Davidson PM. Is verbatim transcription of interview data always necessary? Appl Nurs Res. 2006;19(1):38\u201342.","journal-title":"Appl Nurs Res"},{"key":"1565_CR28","doi-asserted-by":"publisher","unstructured":"Cappelleri JC, Zou KH, Bushmakin AG, Alvir JMJ, Alemayehu D, Symonds T. Patient-Reported Outcomes: Measurement, Implementation and Interpretation (1st ed.). Chapman and Hall\/CRC; 2014. https:\/\/doi.org\/10.1201\/b16139","DOI":"10.1201\/b16139"},{"issue":"2","key":"1565_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94\u2013104.","journal-title":"Value Health"},{"issue":"2","key":"1565_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/hex.12462","volume":"20","author":"M Murphy","year":"2017","unstructured":"Murphy M, Hollinghurst S, Salisbury C. Agreeing the content of a patient-reported outcome measure for primary care: a Delphi consensus study. Health Expect. 2017;20(2):335\u201348.","journal-title":"Health Expect"},{"key":"1565_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/9781394260645","volume-title":"Internet, phone, mail, and mixed-mode surveys: the tailored design method","author":"DA Dillman","year":"2014","unstructured":"Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method.\u00a0Hoboken, NJ: Wiley; 2014."},{"key":"1565_CR32","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655","volume-title":"Cognitive interviewing - a tool for improving questionnaire design","author":"GB Willis","year":"2005","unstructured":"Willis GB. Cognitive interviewing - a tool for improving questionnaire design. Thousand Oaks: Sage; 2005."},{"issue":"7","key":"1565_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1565_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00004356-200409000-00013","volume":"27","author":"C Gagnon","year":"2004","unstructured":"Gagnon C, Desrosiers J, Mathieu J. Autosomal recessive spastic ataxia of Charlevoix-Saguenay: upper extremity aptitudes, functional independence and social participation. Int J Rehabil Res. 2004;27(3):253\u20136.","journal-title":"Int J Rehabil Res"},{"issue":"1","key":"1565_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13023-018-0898-z","volume":"13","author":"C Gagnon","year":"2018","unstructured":"Gagnon C, et al. From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay. Orphanet J Rare Dis. 2018;13(1):165.","journal-title":"Orphanet J Rare Dis"},{"key":"1565_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2018.03.033","volume":"390","author":"I Lessard","year":"2018","unstructured":"Lessard I, et al. Assessing mobility and balance in autosomal recessive spastic ataxia of Charlevoix-Saguenay population: validity and reliability of four outcome measures. J Neurol Sci. 2018;390:4\u20139.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1565_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13023-021-02054-2","volume":"16","author":"I Lessard","year":"2021","unstructured":"Lessard I, et al. Functional mobility in walking adult population with ataxia of Charlevoix-Saguenay. Orphanet J Rare Dis. 2021;16(1):432.","journal-title":"Orphanet J Rare Dis"},{"issue":"14","key":"1565_CR38","doi-asserted-by":"publisher","first-page":"e1307","DOI":"10.1212\/WNL.0000000000006290","volume":"91","author":"C Gagnon","year":"2018","unstructured":"Gagnon C, et al. An exploratory natural history of ataxia of Charlevoix-Saguenay: a 2-year follow-up. Neurology. 2018;91(14):e1307\u201311.","journal-title":"Neurology"},{"issue":"1","key":"1565_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"key":"1565_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","volume":"6","author":"GO Boateng","year":"2018","unstructured":"Boateng GO, et al. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149.","journal-title":"Front Public Health"},{"key":"1565_CR41","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in medicine: a practical guide","author":"HCW de Vet","year":"2011","unstructured":"de Vet, H. C. W., Terwee, C. B., Mokkink, L. B., & Knol, D. L. Measurement in medicine: a practical guide.\u00a0Cambridge, UK: Cambridge University Press; 2011."},{"key":"1565_CR42","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511779633","volume-title":"The Cambridge dictionary of statistics","author":"BS Everitt","year":"2010","unstructured":"Everitt BS, Skrondal A. The Cambridge dictionary of statistics.\u00a0Cambridge, UK: Cambridge University Press; 2010."},{"key":"1565_CR43","doi-asserted-by":"crossref","unstructured":"Forsythe L, et al. Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute. Qual Life Res. 2017;27(1):17\u201331.","DOI":"10.1007\/s11136-017-1581-x"},{"issue":"2","key":"1565_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1377\/hlthaff.2012.1133","volume":"32","author":"KL Carman","year":"2013","unstructured":"Carman KL, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff (Millwood). 2013;32(2):223\u201331.","journal-title":"Health Aff (Millwood)"},{"key":"1565_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1565_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1207\/S15327752JPA8001_18","volume":"80","author":"DL Streiner","year":"2003","unstructured":"Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99\u2013103.","journal-title":"J Pers Assess"},{"key":"1565_CR47","volume-title":"Description des traits de personnalit\u00e9 et de l'adaptation sociale chez des personnes atteintes d'ataxie r\u00e9cessive spastique de Charlevoix-Saguenay","author":"G Forgue","year":"2019","unstructured":"Forgue G, Bouchard J, Gallais B. Description des traits de personnalit\u00e9 et de l'adaptation sociale chez des personnes atteintes d'ataxie r\u00e9cessive spastique de Charlevoix-Saguenay. Universit\u00e9 du Qu\u00e9bec \u00e0 Chicoutimi; 2019. Retrieved from https:\/\/constellation.uqac.ca\/5178\/1\/Forgues_uqac_0862D_10571.pdf"},{"key":"1565_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"YS Lincoln","year":"1985","unstructured":"Lincoln YS, Guba EG. Naturalistic inquiry. USA: Sage Publications; 1985."},{"issue":"6","key":"1565_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s12311-019-01052-2","volume":"18","author":"M Beaudin","year":"2019","unstructured":"Beaudin M, et al. The classification of autosomal recessive cerebellar ataxias: a consensus statement from the Society for Research on the Cerebellum and Ataxias Task Force. Cerebellum. 2019;18(6):1098\u2013125.","journal-title":"Cerebellum"},{"issue":"3","key":"1565_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/mds.26944","volume":"32","author":"M Synofzik","year":"2017","unstructured":"Synofzik M, Sch\u00fcle R. Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways. Mov Disord. 2017;32(3):332\u201345.","journal-title":"Mov Disord"},{"issue":"2","key":"1565_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/00273170902794206","volume":"44","author":"JCF de Winter","year":"2009","unstructured":"de Winter JCF, Dodou D, Wieringa PA. Exploratory factor analysis with small sample sizes. Multivar Behav Res. 2009;44(2):147\u201381.","journal-title":"Multivar Behav Res"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-023-01565-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T05:19:05Z","timestamp":1710825545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-023-01565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s12311-023-01565-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2511782\/v1","asserted-by":"object"}]},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"3 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Comit\u00e9 d\u2019\u00e9thique de la recherche du Centre int\u00e9gr\u00e9 universit\u00e9 en sant\u00e9 et services sociaux (CIUSSS) du Saguenay-Lac-Saint-Jean (reference number 2018\u2013052). Informed consent to participate and to publish was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}